2SANTOS S H S,FERNANDES L R,MARIO tG, et al. Mas de-ficiency in FVB/N mice produces marked changes in lipid and gly-cemic metabolism[ J]. Diabetes, 2008,57(2) : 340 -347.
3LIU C,LV X H, LI H X, et al. Angiotensin -(1 -7) suppressesoxidative stress and improves glucose uptake via Mas receptor inadipocytes[ J]. Acta Diabetol, 2012, 49(4) : 291 -299.
4LEUNG P S, CARLSSON P 0. Pancreatic islet renin angiotensinsystem: its novel roles in islet function and in diabetes mellitus[J]. Pancreas, 2005, 30(4) : 293 -298.
5DONOGHUE M, HSIEH F,BARONAS E,et al. A novel angio-tensin -converting enzyme - related carboxypeptidase ( ACE2 )converts angiotensin I to angiotensin 1 -9[ J]. Circu Res,2000,87(5) : el -e9.
6TIPNIS S R,HOOPER N M, HYDE R, et al. A human homologof angiotensin - converting enzyme cloning and functional expres-sion as a captopril - insensitive carboxypeptidase[ J]. J Biol Chem,2000,275(43) : 33238 -33243.
7TIKELLIS C,BERNARDI S,BURNS W C. Angiotensin - conver-ting enzyme 2 is a key modulator of the renin - angiotensin systemin cardiovascular and renal disease[ J]. Curr Opin Nephrol Hyper-tens, 2011,20(1) : 62 -68.
8CHHABRA K H, XIA H, PEDERSEN K B, et ai. Pancreatic angio-tensin -converting enzyme 2 improves glycemia in angiotensin II -infused mice [ J ]. Am J Physiol Endocrinol Metab, 2013 , 304(8): E874 -E884.
9BINDOM S M,HANS C P,XIA H, et al. Angiotensin I - Conver-ting Enzyme Type 2 ( ACE2) Gene Therapy Improves GlycemicControl in Diabetic Mice[J]. Diabetes,2010,59(10) : 2540 -2548.
10VICKERS C, HALES P, KAUSHIK V, et al. Hydrolysis of bio-logical peptides by human angiotensin - converting enzyme - relat-ed carboxypeptidase[ J]. J Biol Chem, 2002, 277 (17) : 14838 -14843.
二级参考文献38
1Giani JF,Gironacci MM,Mu(n)oz MC,et al.Angiotensin-(1-7)stimulates the phosphorylation of JAK2,IRS-1 and Akt in rat heart in vivo:role of the AT1 and Mas receptors.Am J Physiol Heart Circ Physiol,2007,293:H1154-H1163.
2Santos RA,Ferreira AJ,Simoes E Silva AC,et al.Recent advances in the angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis.Exp Physiol,2008,93:519-527.
3Velloso LA,Folli F,Perego L,et al.The multi-faceted cross-talk between the insulin and angiotensin Ⅱ signaling systems.Diabetes Metab Res Rev,2006,22:98-107.
4Leibiger IB,Leibiger B,Berggren PO.Insulin signaling in the pancreatic beta-cell.Annu Rev Nutr,2008,28:233-251.
6Kulkarni RN,BrüningJC,WinnayJN,et al.Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.Cell,1999,96:329-339.
7Otani K,Kulkami RN,Baldwin AC,et al.Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in beta IRKO mice.Am J Physiol Endocrinol Metab,2004,286:F41-E49.
8Tikellis C,Wookey PJ,Candido R,et al.Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat.Diabetes,2004,53:989-997.
9Santos RA,Simoes e Silva AC,Maric C,et al.Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.Proc Natl Acad Sci USA,2003,100:8258-8263.
10Gironacci MM,Cobs MP,Pe(n)a C.Angiotensin-(1-7) binds at the type 1 angiotensin Ⅱ receptors in rat renal cortex.Regul Pept,1999,84:51-54.
